Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 14/20 | 0.68 |
| ▸ | MDM4 | O15151 | 10/20 | 0.68 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.50 |
| ▸ | EIF4E | P06730 | 1/20 | 0.48 |
| ▸ | EIF4EBP1 | Q13541 | 1/20 | 0.48 |
| ▸ | RXFP4 | Q8TDU9 | 1/20 | 0.48 |
| ▸ | KRAS | P01116 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16167588 | 0.98 | MDM2 (0.64) | MDM2MDM4PCSK9EIF4EEIF4EBP1 | |
| SCHEMBL18057199 | 0.94 | MDM2 (0.59) | MDM2MDM4PCSK9RXFP4 | |
| SCHEMBL18057198 | 0.92 | MDM2 (0.56) | MDM2MDM4PCSK9RXFP4 | |
| SCHEMBL19406735 | 0.85 | MDM2 (0.62) | MDM2MDM4PCSK9ESR1 | |
| SCHEMBL19406734 | 0.85 | MDM2 (0.67) | MDM2MDM4PCSK9EIF4EEIF4EBP1 | |
| SCHEMBL16351424 | 0.84 | MDM2 (0.53) | MDM2MDM4PCSK9 | |
| SCHEMBL15183813 | 0.83 | MDM2 (0.66) | MDM2MDM4PCSK9EIF4EEIF4EBP1 | |
| SCHEMBL16351425 | 0.82 | MDM4 (0.49) | MDM2MDM4PCSK9 | |
| SCHEMBL17880430 | 0.80 | MDM2 (0.78) | MDM2MDM4PCSK9EIF4EEIF4EBP1 | |
| SCHEMBL12297508 | 0.78 | MDM2 (0.58) | MDM2MDM4PCSK9EIF4EEIF4EBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8859723-B2 | Peptidomimetic macrocycles | AILERON THERAPEUTICS, INC. (US) | 2014-10-14 | — | — | US | disclosed |